Researchers have introduced DiffSMol, a generative AI model capable of generating realistic 3D structures of small molecules ...

HHM Health pharmacy director Dr. Riz Islam and Fox News host Will Cain explain why America has uniquely high drug prices on ...

The healthcare and medical industries are increasingly integrating artificial intelligence into their operations, ...

OpenAI has reportedly met with officials from the U.S. Food and Drug Administration (FDA) to discuss the use of artificial ...

Randomised controlled trials are the gold standard to assess the effectiveness and safety of clinical interventions; however, ...

Recursion Pharmaceuticals could benefit from FDA’s AI shift despite risks, with scalable tech and long-term potential. Find ...

The recipients include innovators who have created breakthroughs in knowledge and technology that are improving our world and ...

The US Food and Drug Administration (FDA) recently announced a strategic roadmap to phase out animal testing requirements for certain drug ...

The global biosimulation market, valued at approximately USD 3.1 billion in 2022, is on track to experience significant growth over the next decade. Projected to expand at a compound annual growth ...

Confusion over the U.S. Food and Drug Administration delay in granting ... a step that would cost the company tens of millions of dollars and delay by months if not longer full approval of the ...